HIV, Malaria Supply Chain at Risk as US Overhauls Global Health Aid

The US is restructuring its global health aid system, relacing contractors with direct country deals. Experts warn this rapid transition could disrupt supply chains, risking shortages of critical HIV and malaria medicines in vulnerable countries.

Post Published By: Karan Sharma

Updated : 4 April 2026, 7:17 PM IST

Global Drug Crisis Looming Due to US Decision (Image Source: Internet)

New Delhi: The United States is currently altering its approach to delivering medicines for diseases like HIV and malaria to low-income nations. Previously, this task was managed through a large-scale supply system; however, the government is now preparing to overhaul this entire framework.

This decision could potentially impact the supply of essential medicines in numerous countries.

How Was the Process Handled Previously?

Until now, this operation was conducted under the “Global Health Supply Chain Program,” which was administered by an organization named Chemonics.

Between 2016 and 2024, this program delivered:

• Medicines worth over $5 billion to 90 countries
• Providing particular assistance to low-income nations in Africa and Asia

These medicines included essential treatments for the prevention and management of HIV, AIDS, and malaria.

Why the Sudden Change in the System?

Upon assuming office, Donald Trump decided to scale back and restructure foreign aid initiatives. Major institutions like USAID were weakened. Direct bilateral agreements with recipient nations began to replace the use of contractors. Budgetary allocations were also reduced. The government asserts that the previous system was “expensive and inefficient.”

What Could Be the Impact?

According to experts and informed sources, this rapid transition could lead to the following consequences:

• Shortages of medicines may arise in several countries.
• Patients suffering from HIV and malaria may be unable to access timely treatment.
• There is a risk of the supply chain collapsing.

It has also been warned that if these changes are implemented hastily, they could result in “disruptions to life-saving services.”

What Is the New Plan?

The United States now intends to work directly with the governments of recipient nations and will utilize private logistics firms for distribution.

Additionally, discussions are underway regarding a collaboration with the Global Fund to Fight AIDS, Tuberculosis, and Malaria to facilitate the supply of medicines. However, experts believe that this transition takes time. Delivering medicines to remote areas could take up to a year.

What is the real concern?

The greatest concern is that the existing system is being abruptly shut down. The new system is not yet fully prepared. In the interim, patients' lives could be put at risk.